INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 10.94 Billion | 5.6% | North America |
| By Product | By Procedure | By Application |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Radiotherapy Market OverviewÂ
The global radiotherapy market will witness a CAGR of 5.6% for the forecast period of 2022-2029. It is expected to reach above USD 10.94 Billion by 2029 from USD 6.70 Billion in 2020.
The demand for radiotherapy has experienced notable growth in recent years, primarily attributable to several factors including the increasing incidence of cancer, a growing geriatric population, heightened adoption of radiotherapy devices and procedures, as well as a surge in awareness campaigns highlighting the benefits of radiotherapy, coupled with advancements in radiotherapy technologies. Nevertheless, challenges such as a shortage of skilled personnel and difficulties in tumor visualization have impeded the expansion of the radiotherapy market.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Product, By Procedure, By Application, By End-User, By Region |
| By Product |
|
| By Procedure
|
|
| By Application
|
|
| By End-User
 |
|
| By Region
|
|
However, growth opportunities abound in emerging markets, driven by an increasing demand for cancer treatment. Factors propelling segment growth include the rising incidence of skin and lip cancer, robust research and development (R&D) efforts, technological advancements in radiotherapy, a growing preference for non-invasive cancer treatments such as radiotherapy, and improved accessibility to radiotherapy services globally. For instance, data from the American Cancer Society indicates a projected 97,610 cases of melanoma, comprising 58,120 men and 39,490 women in the United States by the end of 2023, underscoring the significant demand for radiotherapy devices for treatment purposes, thereby fostering market expansion.
Moreover, the swift economic development witnessed in developing nations like China and India presents substantial growth prospects for the radiotherapy market. Factors such as the rapid increase in per-capita healthcare expenditure, governmental focus on enhancing healthcare infrastructure and services, coupled with a rising cancer patient population and heightened awareness, contribute significantly to market growth. Additionally, greater affordability of healthcare services further fuels the demand for radiotherapy. Manufacturers of radiotherapy equipment are actively seeking collaborations with healthcare providers in these regions to bolster their market presence. Collectively, these factors are anticipated to catalyze rapid market growth in these nations.
Radiotherapy Market Segment Analysis
The global radiotherapy market is segmented based on the radiotherapy market into product, procedure, application, end-user, and region. By radiotherapy market product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End-User (Hospitals, Independent Radiotherapy Centers), for a significant share of the overall market. The segment is expected to grow significantly over the forecast period as a result of a combination of high-quality service and an increased rising preference for non-surgical procedures and efficiency in large-scale projects.
By product, linear accelerators (LINACs), particle therapy systems, and traditional cobalt-60 teletherapy devices are the different types of EBRT products. In 2020, the linear accelerator category had the biggest market share among EBRT products. In EBRT, the linear accelerator is the primary and most commonly used therapy unit. The LINAC segment is further divided into stereotactic advanced electron/cobalt-60 LINAC systems and traditional LINAC systems. LINAC devices enhance the velocity of charged subatomic particles along a linear route using high-energy radiofrequency electromagnetic waves. A modulator, gantry, electron gun, RF power supply, and accelerator guide are the main components of these accelerators. The employment of LINACs with IMRT, IGRT, 3D conformal radiation (3D-CRT), and stereotactic technologies is possible. Traditional EBRT, such as IMRT, IGRT, volumetric modulated arc treatment (VMAT), SRS, and SBRT, is delivered by medical LINAC systems, which are the most extensively utilized devices.
By procedure, IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT are several types of external beam radiotherapy. In 2020, the IGRT segment held the largest proportion of the external beam radiotherapy market. IGRT uses images collected before and during treatment to allow radiation oncologists to modify the patient’s position to accurately target the tumor while limiting exposure to healthy areas. Longer treatment planning and procedure timing, as well as errors owing to the patient placement and a lack of suitable dosage management equipment advice (particularly in emerging countries), may represent a hindrance to the IGRT market’s growth. Furthermore, image-guided radiation therapy adds to the complexity of radiation planning and delivery by requiring high-quality assurance at every stage. This is critical for effective and safe treatment.
By application, prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other malignancies are the segments of the internal beam radiotherapy/brachytherapy applications market. During the projection period, the breast cancer category grew at the fastest rate in the internal beam radiotherapy applications market. Brachytherapy is widely utilized as an alternative to whole-breast external radiation therapy. HDR brachytherapy gives a precise, highly concentrated radiation dose to the target tumor in a shorter treatment period with less radiation exposure to healthy breast tissue. Brachytherapy also aids in the preservation of the majority of healthy breast tissues, preserving the breast’s aesthetic appearance. Brachytherapy has become the gold standard for the treatment of breast cancer as a result of all of these causes. HDR brachytherapy is used to treat early-stage breast cancer, locally progressed breast cancer with no metastases, and chest-wall breast cancer (which cannot be treated surgically).
Based on end-user, in 2019, hospitals held the highest proportion of the worldwide radiation market. One of the primary factors leading to the growth of the radiation market for hospitals is the expanding number of private hospitals in emerging nations, combined with the vast pool of cancer patients visiting hospitals for diagnosis and treatment. According to the Commonwealth Fund, China’s overall number of hospitals has expanded dramatically over the last decade, from around 18,700 in 2005 to 27,600 in 2015 and 31,056 in 2017. Other significant factors supporting the growth of the radiotherapy market in hospitals are growing healthcare infrastructure and increased accessibility to healthcare services through wider adoption of health insurance.
Radiotherapy Market Players
The radiotherapy market key players include Varian Medical Systems, Inc., Elekta, Accuray Incorporated, Ion Beam Applications SA, Eckert & Ziegler, BD, Hitachi Ltd., ICAD, Inc., IntraOp Medical, Inc., ViewRay, Inc., Panacea Medical Technologies Pvt. Ltd., P-cure Ltd., Mevion Medical Systems, Inc., IsoRay Medical, Inc., ZEISS Group. The market players have been on the way to adopting various kinds of organic and inorganic growth strategies, like new product developments and launches, acquisitions, and merger contracts.
To increase their market position, these businesses have implemented a variety of growth tactics. These companies are using expansion, new product development, mergers, and acquisitions, and collaboration as important growth strategies to improve their product portfolio and geographical presence to meet the rising demand for the radiotherapy market from emerging economies.
Who Should Buy? Or Key stakeholders
- Healthcare Companies
- Institutional & retail players.
- Investment research firms
- others
Key Takeaways:
- The global radiotherapy market will witness a CAGR of 5.6% for the forecast period.
- By product, the linear accelerator category had the biggest market share.
- By procedure, the IGRT segment held the largest proportion of the external beam radiotherapy market.
- By application, the breast cancer category grew at the fastest rate.
- Based on end-user, hospitals held the highest proportion of the worldwide radiation market.
- North America is the largest market for radiotherapy market.
- The global radiotherapy market is experiencing steady growth driven by technological advancements and increasing cancer incidence.
Radiotherapy Market Regional Analysis
The radiotherapy market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and the Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
- South America: includes Brazil, Argentina, and the Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA
North America is the largest market for radiotherapy market due to the sheer increasing high acceptance of radiotherapy for the treatment of cancer diseases in the region, North America is predicted to dominate the global radiotherapy market in the next years. Because of the continuing rise in the number of cancer patients in the United States, the United States is predicted to dominate the radiotherapy industry and lead growth in the North American area. In the Asia-Pacific region, China is likely to lead the radiotherapy industry. With expanding government measures for awareness regarding the necessity of diagnosis, China is one of the leading countries in the world with a fast-increasing diagnostic rate. With the increased use of radiotherapy in breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and other cancers in the region, Europe is predicted to develop at the fastest rate from 2022 to 2029. Due to its developed medical infrastructure and the existence of a significant number of market competitors, Germany is likely to dominate the radiotherapy industry in Europe.
The increasing use of innovative medical device technologies, growing digitalization of medical equipment, increased emphasis on improving treatment results, and the rising prevalence of cancer are all driving the market’s expansion in the country. According to the American Society for Radiation Oncology, roughly 13,800 women in the United States were diagnosed with cervical cancer in 2020. Furthermore, according to the Breast Cancer Organization’s data, one out of every eight women (about 12 percent) may acquire invasive breast cancer during her lifetime.
The market has been divided worldwide based on region into the North American region, Asia-Pacific region, European region, Latin American region, and the Middle East and African region.
Due to the presence of major key players, North America dominates the radiotherapy market. These major key players adopt various strategies to endure their market position in the radiotherapy market in the global market by going for mergers, and acquisitions, collaborating, setting up a new joint venture, establishing a partnership, developing a new product line, innovating in the existing product, developing a unique production process, and many others to expand their customer base in the untapped market of the radiotherapy market all across the globe.
Key Market Segments: Radiotherapy Market
Global Radiotherapy Market By Product, 2020-2029, (USD Million)
- External Beam Radiotherapy
- Electron-emitting High-energy Linear Accelerators
- Conventional Linear Accelerators
- Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
- Gamma Knife
- CyberKnife
- TomoTherapy
- Conventional Cobalt-60 Teletherapy Units
- Particle Therapy Systems
- Cyclotrons
- Synchrotrons
- Synchrocyclotron
- Internal Beam Radiotherapy/Brachytherapy
- Seeds
- Afterloaders
- Applicators
- IORT Systems
- Systemic Radiotherapy
- Iobenguane (I-131)
- Samarium-153
- Rhenium-186
- Other Systemic Radiotherapy Products
Global Radiotherapy Market by Procedure, 2020-2029, (USD Million)
- External Beam Radiotherapy
- Image-guided Radiotherapy
- Intensity-modulated Radiotherapy
- Stereotactic Therapy
- Particle Therapy
- 3D Conformal Radiotherapy
- Internal Beam Radiotherapy/Brachytherapy
- High-dose-rate Brachytherapy
- Low-dose-rate Brachytherapy
- Pulsed-dose-rate Brachytherapy
- Systemic Radiotherapy
- Intravenous Radiotherapy
- Oral Radiotherapy
- Installation Radiotherapy
Global Radiotherapy Market by Application, 2020-2029, (USD Million)
- External Beam Radiotherapy
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Other Cancers
- Internal Beam Radiotherapy/Brachytherapy
- Prostate Cancer
- Gynecological Cancer
- Breast Cancer
- Cervical Cancer
- Penile Cancer
- Other Cancers
Global Radiotherapy Market by End-User, 2020-2029, (USD Million)
- Hospitals
- Independent Radiotherapy Centers
Global Radiotherapy Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Key Question Answered
- What is the current size of the radiotherapy market?
- What are the key factors influencing the growth of the radiotherapy market?
- What are the major applications for the radiotherapy market?
- Who are the major key players in the radiotherapy market?
- Which region will provide more business opportunities for the radiotherapy market in the future?
- Which segment holds the maximum share of the radiotherapy market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL RADIOTHERAPY MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON GLOBAL RADIOTHERAPY MARKET
- GLOBAL RADIOTHERAPY MARKET OUTLOOK
- GLOBAL RADIOTHERAPY MARKET BY PRODUCT, (USD MILLION) (THOUSAND UNITS)
- EXTERNAL BEAM RADIOTHERAPY
- ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS
- CONVENTIONAL LINEAR ACCELERATORS
- STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS
- GAMMA KNIFE
- CYBERKNIFE
- TOMOTHERAPY
- CONVENTIONAL COBALT-60 TELETHERAPY UNITS
- PARTICLE THERAPY SYSTEMS
- CYCLOTRONS
- SYNCHROTRONS
- SYNCHROCYCLOTRON
- INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
- SEEDS
- AFTERLOADERS
- APPLICATORS
- IORT SYSTEMS
- SYSTEMIC RADIOTHERAPY
- IOBENGUANE (I-131)
- SAMARIUM-153
- RHENIUM-186
- OTHER SYSTEMIC RADIOTHERAPY PRODUCTS*
- GLOBAL RADIOTHERAPY MARKET BY PROCEDURE, (USD MILLION)
- EXTERNAL BEAM RADIOTHERAPY
- IMAGE-GUIDED RADIOTHERAPY
- INTENSITY-MODULATED RADIOTHERAPY
- STEREOTACTIC THERAPY
- PARTICLE THERAPY
- 3D CONFORMAL RADIOTHERAPY
- INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
- HIGH-DOSE-RATE BRACHYTHERAPY
- LOW-DOSE-RATE BRACHYTHERAPY
- PULSED-DOSE-RATE BRACHYTHERAPY
- SYSTEMIC RADIOTHERAPY
- INTRAVENOUS RADIOTHERAPY
- ORAL RADIOTHERAPY
- INSTALLATIONLATION RADIOTHERAPY
- EXTERNAL BEAM RADIOTHERAPY
- GLOBAL RADIOTHERAPY MARKET BY APPLICATION, (USD MILLION)
- EXTERNAL BEAM RADIOTHERAPY
- PROSTATE CANCER
- BREAST CANCER
- LUNG CANCER
- HEAD AND NECK CANCER
- COLORECTAL CANCER
- OTHER CANCERS
- INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
- PROSTATE CANCER
- GYNECOLOGICAL CANCER
- BREAST CANCER
- CERVICAL CANCER
- PENILE CANCER
- OTHER CANCERS
- EXTERNAL BEAM RADIOTHERAPY
- GLOBAL RADIOTHERAPY MARKET BY END USER, (USD MILLION) (THOUSAND UNITS)
- HOSPITALS
- INDEPENDENT RADIOTHERAPY CENTERS
- GLOBAL RADIOTHERAPY MARKET BY REGION, (USD MILLION) (THOUSAND UNITS)
- INTRODUCTION
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA-PACIFIC
- NORTH AMERICA
- UNITED STATES
- CANADA
- MEXICO
- EUROPE
- GERMANY
- UNITED KINGDOM
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, TYPES OFFERED, RECENT DEVELOPMENTS)
- VARIAN MEDICAL SYSTEMS, INC.
- ELEKTA
- ACCURAY INCORPORATED
- ION BEAM APPLICATIONS SA
- ECKERT & ZIEGLER
- BD
- HITACHI LTD.
- ICAD, INC.
- INTRAOP MEDICAL, INC.
- VIEWRAY, INC.
- PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
- P-CURE LTD.
- MEVION MEDICAL SYSTEMS, INC.
- ISORAY MEDICAL, INC.
- ZEISS GROUP (BUSINESS OVERVIEW, COMPANY SNAPSHOT, TYPES OFFERED, RECENT DEVELOPMENTS) *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA RADIOTHERAPY MARKET BY COUNTRY (USD MILLIONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â US RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA RADIOTHERAPY MARKET BY COUNTRY (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC RADIOTHERAPY MARKET BY COUNTRY (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE RADIOTHERAPY MARKET BY COUNTRY (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â UK RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â UK RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â UK RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â UK RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET BY COUNTRY (USD MILLIONS) 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â UAE RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â UAE RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â UAE RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â UAE RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY PROCEDURE (USD MILLIONS) 2020-2029
FIGURE 10Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
FIGURE 11Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY END USER (USD MILLIONS) 2020-2029
FIGURE 12Â Â Â Â Â Â GLOBAL RADIOTHERAPY MARKET BY REGION (USD MILLIONS) 2020-2029
FIGURE 13      PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â EUROPE RADIOTHERAPY MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â ASIA PACIFIC RADIOTHERAPY MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT
FIGURE 18Â Â Â Â Â Â MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SNAPSHOT
FIGURE 19Â Â Â Â Â Â VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â ELEKTA: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â ACCURAY INCORPORATED: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â ION BEAM APPLICATIONS SA: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â ECKERT & ZIEGLER: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â BD: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â HITACHI LTD.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â ICAD, INC.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â INTRAOP MEDICAL, INC.: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â VIEWRAY, INC.: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â Â Â P-CURE LTD.: COMPANY SNAPSHOT
FIGURE 31Â Â Â Â Â Â MEVION MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
FIGURE 32Â Â Â Â Â Â ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
FIGURE 33Â Â Â Â Â Â ZEISS GROUP: COMPANY SNAPSHOT
FAQ
The radiotherapy market size had crossed USD 6.70 Billion in 2020 and will observe a CAGR of more than 5.6% up to 2029 driven by the increase in the number of cancer patients, a rise in the geriatric population, and an increase in the adoption of radiotherapy devices and procedures.
North America held more than 48% of the radiotherapy market revenue share in 2020 and will witness expansion as increasing high acceptance of radiotherapy for the treatment of cancer diseases and the technological development of radiotherapy accelerate in countries, US, Canada, Mexico.
The global radiotherapy market registered a CAGR of 5.6% from 2022 to 2029. By deployment mode, the linear accelerator in the EBRT products segment accounted for the greatest segmental revenue in the radiotherapy market in 2020 and is likely expected to have the biggest market segment was the highest revenue contributor to the market.
The breast cancer category grew at the fastest rate in the internal beam radiotherapy applications is also a major driver segment of the global radiotherapy.
North America is accounted for the highest share of the global radiotherapy market.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.